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Abstract. In this work we develop the 2D model suggested in [32] in order to study the impact
of fibrinogen concentration and the fibrin polymer production rate on clot growth in flow. The
model is based on the method of Dissipative Particle Dynamics describing blood plasma flow and
platelet suspension and on a system of partial differential equations describing blood coagulation
regulatory network. We study the influence of parameters on clot development and on its final size.
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1. Introduction
Blood coagulation in flow has been extensively studied. However, there are still many open ques-
tions concerning clot growth. This sensitive and crucial mechanism by which the body in higher
animals prevents blood loss is closely related to many blood disorders, i.e. it either affects them
or is being affected by them. In attempts to shed light on the underlying biological, chemical and
mechanical processes, mathematical modelling is becoming increasingly important.
There are three main groups of modelling approaches in studying of blood coagulation: con-
tinuous, discrete and hybrid models. In continuous models [2, 4, 5, 8, 16, 30] the concentrations of
proteins, so-called blood factors, are described by systems of partial differential equations. All the
1Corresponding author. E-mail address: tosenberger@math.univ-lyon1.fr
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reactions between blood factors in the process of blood coagulation form a very complex regula-
tory network, generating a large systems of PDEs. Such models are also able to accurately describe
the diffusion of proteins in the flow. However, continuous models do not consider interactions be-
tween blood cells, but rather describe them also in terms of concentrations [30]. Contrary to the
continuous models, the discrete models [13, 25, 29, 33–36] focus on the description of individual
cells and are thus convenient for studying their interactions in flow. Where they come short is in
describing the diffusion of blood factors in the flow. For this reason the third type of approaches
was developed – the so-called hybrid models. Hybrid models combine continuous and discrete
methods in order to describe different aspects of a studied phenomenon. In this sense they are of-
ten considered in terms of multi-scale modelling. In the last decade several different hybrid models
of blood coagulation in flows were developed [12, 13, 25, 29, 33–36].
In our approach to modelling of blood coagulation in flow we have developed a 2D hybrid
model in which a discrete simulation method called Dissipative Particle Dynamics (DPD) is used
to model the suspension of platelets in the plasma flow. The continuous part of the model consists
of a system of partial differential equations describing the concentrations of proteins in the flow
and the corresponding regulatory network. The model is based on several important biological as-
sumptions which have been experimentally confirmed. First, we assume that platelet aggregation
may precede platelet activation [9, 17–20, 24, 37]. This assumption is crucial for faster flows (ar-
terioles, venules) where the initial platelet aggregate protects protein concentrations from the flow,
allowing for the bio-chemical reactions to occur at the injury site [28]. The second assumption
is that the end product of the coagulation reactions, fibrin polymer, forms a net which reinforces
the platelet aggregate. In the third assumption, platelets which are covered by fibrin polymer be-
come non-adhesive [21], and thus cannot attach new platelets from the flow. As a result of this
model we have proposed a new possible mechanism of clot growth and growth arrest in flow in
normal healthy conditions [32]. We will measure the total concentrations of the three proteins in-
cluded in the model (thrombin, fibrinogen, fibrin polymer) and their variations for different values
of parameters.
2. Model description
The 2D hybrid model developed in this work uses the Dissipative Particle Dynamics (DPD) method
to describe the flow of platelet suspension in blood plasma. Concentrations of proteins in the
blood and their diffusion and reactions in the flow are modelled by a system of partial differential
equations. Finally, platelet aggregation is modelled as an interaction between individual platelets
in which they form elastic bonds.
2.1. Flow model
The flow of blood plasma and the suspension of platelets is modelled by DPD. It is a well known
simulation method convenient for modelling hydrodynamics of complex fluids, such as blood [6,
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7,10,11,15,22,26,27]. As a mesoscale method, the particles represent small drops of fluid, rather
than individual atoms or molecules. Between each two particles in some rc > 0 proximity there
exist three pair-wise forces - conservative, dissipative and random force:
FCij = F
C
ij (rij)rˆij, (2.1)
FDij = −γωD(rij)(vij · rˆij)rˆij, (2.2)
FRij = σω
R(rij)
ξij√
dt
rˆij, (2.3)
where ri is the vector of position of the particle i, rij = ri − rj , rij = |rij|, rˆij = rij/rij , and
vij = vi − vj is the difference between the velocities of two particles, γ and σ are coefficients
which determine the strength of the dissipative and the random force respectively, while ωD and ωR
are weight functions; ξij is a normally distributed random variable with zero mean, unit variance,
and ξij = ξji. The conservative force is given by the equality
FCij (rij) =
aij (1− rij/rc) for rij ≤ rc,
0 for rij > rc,
(2.4)
where aij is the conservative force coefficient between particles i and j, and rc is the cut-off radius.
The random and dissipative forces form a thermostat. If the following two relations are satis-
fied, the system will preserve its energy and maintain the equilibrium temperature:
ωD(rij) =
[
ωR(rij)
]2
, σ
2 = 2γkBT, (2.5)
where kB is the Boltzmann constant and T is the temperature. The weight functions are determined
by:
ωR(rij) =
(1− rij/rc)
k for rij ≤ rc,
0 for rij > rc,
(2.6)
where k = 1 for the original DPD method, but it can be also varied in order to change the dynamic
viscosity of the simulated fluid [10]. The motion of particles is determined by Newton’s second
law of motion:
dri = vidt, dvi =
dt
mi
∑
j 6=i
(
FCij + F
D
ij + F
R
ij
)
, (2.7)
where mi is the mass of the particle i.
The simplest way to integrate the equations of motion (2.7) is by use of Euler method. However,
more refined methods, like modified velocity-Verlet method [3, 15], can be used, which allows a
certain increase in the time step dt (by the factor of about 50 [15]). Additionally, the relative
velocity term, vij = vi − vj , in equation (2.2) can be integrated in a semi-implicit way – as
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vni −vn−1j , where n denotes a current time step. The last integration method allows further increase
in time step, however it is not conservative. For this reason it is preferable to verify the obtained
results by comparison to results obtained by one of the first two methods which are conservative.
In this work we have used the last method in combination with the Euler method.
In scope of this work a flow in a vessel of 50 µm in diameter was simulated by 4500 particles
with the DPD time step of 10−5 s. As hydrodynamic properties of blood plasma are close to those
of water, the density and viscosity of the simulated medium were set to 1000 kg/m3 and 1.24mPa·s,
respectively. The mean velocity of the flow in simulations was 18.5 mm/s, which corresponds to
the wall shear rate of 1500 s−1.
2.2. Regulatory network model
The coagulation regulatory network is modelled by a system of partial differential equations. We
consider a minimal scheme of the regulatory network, as shown in Figure 1, which takes into
account the main characteristics of blood coagulation cascade: the initial local activation of pro-
thrombin to thrombin at the injury site, the self-accelerated thrombin production, the production
of fibrin from fibrinogen in the presence of thrombin as an enzyme, and finally the production of
fibrin polymer which forms a fibrin net. The reactions represented in Figure 1 are modelled by the
following system of equations:
dTh
dt
+ ~v · ∇Th = DTh∆Th + k1(Th)(CTh − Th)− λTh,
∂Fg
∂t
+ ~v · ∇Fg = DFg∆Fg − k3(Th)Fg
(
CFp − Fp
)
, (2.8)
∂Fp
∂t
= k3(Th)Fg
(
CFp − Fp
)
,
where Th, Fg and Fp are thrombin, fibrinogen and fibrin polymer concentrations respectively, ~v is
the velocity field obtained form the DPD simulation of blood plasma and platelets, DTh and DFg
are diffusion coefficients for thrombin and fibrinogen respectively, CTh is the initial prothrombin
level, λ is the thrombin degradation constant, and CFp is the maximum local concentration of fibrin
polymer due to saturation. The functions k1(Th) and k3(Th) are reaction rates for the production
of thrombin and fibrin polymer respectively, and they are defined as follows:
k1(Th) = k
0
1
T 2h
T0 + Th
, k3(Th) = k
0
3Th, (2.9)
where k01 , T0 and k
0
3 are some constants. The form of the reaction rate for thrombin k1(Th) is
chosen as in equation (2.9) in order to have a bistable system, with one stable state in T (1)h = 0,
representing the state with no production of thrombin (and thus no coagulation), and the other one
in 0 < T (2)h < CTh , representing the sustainable production of thrombin. Such bistable kinetics
corresponds to biological observations.
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The initial and boundary conditions for thrombin correspond to a small initial production of
thrombin at the injury site due to the presence of tissue factor:
∂Th
∂x
(x, y, t)
∣∣∣∣
x=0,L
=
∂Th
∂y
(x, y, t)
∣∣∣∣
y=0,D
= 0 (2.10)
Th(x, y, t)
∣∣∣∣
t=0
=
1, if x ∈ [wB, wE] and y = 0,0, if x /∈ [wB, wE] or y 6= 0, (2.11)
where [0, L]× [0, D] is the simulation domain, i.e. a part of the blood vessel with the length L and
diameter D, and where [wB, wE]×{0} is the part of the domain representing the vessel injury site.
On the other hand the initial and boundary conditions for fibrinogen represent its constant presence
in the blood:
∂Fg
∂x
(x, y, t)
∣∣∣∣
x=L
=
∂Fg
∂y
(x, y, t)
∣∣∣∣
y=0,D
= 0, (2.12)
Fg(x, y, t)
∣∣∣∣
x=0
= F 0g , Fg(x, y, t)
∣∣∣∣
t=0
= F 0g . (2.13)
The equation for fibrin polymer concentration does not contain the advection and diffusion
terms since fibrin polymers form the fibrin net which cannot diffuse or flow.
Figure 1: Blood coagulation pathway, as described in the model. The model takes into account
the local production of thrombin due to the presence of tissue factor at the injury site, the self-
accelerated thrombin production, and the fibrin polymer production from fibrinogen in the presence
of thrombin as an enzyme.
In order to numerically solve equations (2.8) Alternating Direction Implicit (ADI) method was
used. Diffusion terms was approximated by second order central finite difference scheme, while
first order finite difference upwind scheme was used to approximate advection terms. Although
the regulatory network model is phenomenological, some of values of parameters in equations
(2.8), like diffusion coefficients DTh and DFg , were taken from the more detailed model [23]
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which describes blood coagulation in a quiescent medium. The velocity in the discrete (DPD)
and continuous (PDEs) parts of the model is considered in different reference frames - Lagrangian
and Eulerian. In order to pass from one to another velocities of particles are measured in DPD
on a fixed spatial subdivision of the simulation domain. Additionally, the measurements are done
during short periods, after which the velocity field is obtained by calculating the mean velocity for
each element of the spatial subdivision. The measured velocity field is in Eulerian reference frame
and enters the equations (2.8) via advection terms.
2.3. Platelet aggregation
In the model platelets are considered as single DPD particles, thus the uniform diameter of all
particles, for both plasma and platelets, was set to correspond to the approximate physical diameter
of platelets (2 µm). The concentration of platelets in simulations was set to 3.672 ·1012 L−1, which
is about 10 times higher than the normal concentration of platelets in blood (0.15−0.4 ·1012 L−1).
This is done for two reasons. Firstly, the spatial distribution of platelets in simulations is uniform,
and, as there are no erythrocytes in the flow, platelets do not migrate to the vessel wall. In presence
of erythrocytes platelets are being pushed closer to the vessel wall, thus greatly increasing their
concentration in the near wall region where the clot is formed [7]. Secondly, by increasing the
platelet concentration the clot will grow faster, thus reducing the time necessary to simulate the
clot growth and arrest. Due to elastic properties of the blood clot, the model of platelet aggregation
is based on Hooke’s law. In case of a physical contact between two platelets a spring connection
between them is established:
FAij = f
A(tij)
(
1− rij
dC
)
rˆij, (2.14)
where dC is a critical distance after which the connection breaks, tij is the age of the connection,
and fA(tij) is a function of the connection strength given by:
fA(tij) =

fA1 if Fp(i) or Fp(j) < cFp , and tij < tc,
fA2 if Fp(i) or Fp(j) < cFp , and tij ≥ tc,
fA3 if Fp(i) and Fp(j) ≥ cFp ,
(2.15)
where fA1 < f
A
2 < f
A
3 are the three strengths of inter-platelet connections, representing respec-
tively a weak bond due to GPIb receptors, a medium bond due to platelet activation and a strong
bond due to the reinforcement by the fibrin polymer net. Next, tc is the time needed for platelet
activation measured from the moment when the connection was established, Fp(i) and Fp(j) is
the concentration of fibrin polymer Fp at the positions of particles i and j respectively, cFp is the
critical level of fibrin polymer. A platelet is considered to be covered by the fibrin net if the fibrin
polymer concentration becomes larger than cFp at the position of that platelet. Such platelets are
adhesion resistant [21] and cannot attach new platelets from the flow. The choice of step function
(equation (2.15)) for modelling platelet activation (depending on tc) is explained in [31, 32].
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Figure 2: A snapshot from a simulation of clot growth with the hybrid model. Green particles
show platelets, while dark green are platelets covered by the fibrin net. The fibrin net is denoted by
the blue colour. The lines between platelets show the corresponding connections and their types:
light red for the weak aggregate, dark red for activated platelets and black for platelets covered in
fibrin polymer.
The DPD model of the flow (Section 2.1.) and the platelet aggregation model (Section 2.3.)
joined with the regulatory network model (Section 2.2.) make a hybrid (discrete-continuous) model
of blood coagulation. Both the discrete and the continuous part influence each other. On the one
hand the discrete part of the model (DPD) together with platelet aggregation at the injury site
influences the concentrations of blood factors via advective terms in equations (2.8). On the other
hand the concentration of fibrin polymer influences the stability of the growing platelet clot and
thus indirectly changes the flow properties.
3. Results
The process of clot growth simulated with this model can be described as follows: a) the initial
weak aggregate is formed at the injury site (0-1 s), b) it is reinforced by platelet activation (1-2
s), c) the decreased flow speed inside of the platelet aggregate enables the accumulation of protein
concentrations and the beginning of bio-chemical reactions which result in the formation of the
fibrin net (2-7 s), d) the fibrin net reinforces the clot and allows its further growth (7-14 s), e)
the growing clot narrows the blood vessel, increasing the flow pressure on the clot, which results
in a breaking of its weaker outer parts (14-30 s), f) after several detachments of outer parts only
the stable part of the clot, covered by fibrin polymer, is left at the injury site (30 s), g) due to the
non-adhesive effect of fibrin polymer, the remaining clot cannot attach new platelets from the flow,
thus it stops growing. The time spans of clot growth stages (given in the brackets) are obtained
from a single simulation. In that simulation the total time of clot growth was about 30 seconds,
however this value can vary depending on the values of simulation parameters. The described
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mechanism of clot growth was suggested in [32] where a simplified model of blood coagulation
reactions described by a single reaction-diffusion equation was considered. In this work we observe
it and study for a more complete model of blood coagulation described by three reaction-diffusion
equations. A snapshot from a simulation is given in Figure 2, showing a clot structure in the stage
d) of the described clot growth. Figure 3 shows distributions of velocity and protein concentrations
at the final stage of the clot growth.
Figure 3: Velocity and concentrations profiles at the fully developed clot stage: a) distribution of
the component of velocity parallel to the flow axis, b) distribution of the component of velocity
perpendicular to the flow axis, c) thrombin distribution, d) fibrinogen distribution, e) fibrin polymer
distribution. The flow is from left to right.
The described process of clot formation depends on the interaction between the platelet aggre-
gate and protein reactions in the flow. Without any of them the clot is unable to form in faster flows
(arterioles, venules). In this work we observe the total concentrations of simulated blood factors
(thrombin, fibrinogen and fibrin polymer) and we study the impact of the most important parame-
ters. For this purpose we simulated blood flow in a channel of 50 µm in diameter with average flow
speed of 12.5 mm/s. The values of strength coefficients of platelet bonds were set to fA1 = 0.4
nN, fA2 = 0.8 nN, f
A
3 = 10 nN, with the platelet activation time tc = 0.3 s. The strengths of
inter-platelet bonds are in a similar range as observed by a discrete model of platelet aggregation
described in [25]. For the basic simulation the values of PDEs’ parameters were set to the fol-
lowing: diffusion coefficients DTh , DFg = 0.003 mm
2/min, thrombin degradation rate constant
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λ = 1.2 · 104 min−1, thrombin and fibrin polymer production rate constants k01 = 3.3 · 104 min−1
and k03 = 6 min
−1 respectively, while the concetrations were considered in the non-dimensional
units T0 = 0.1, initial prothrombin level CTh = 1, maximum local concentration of fibrin polymer
CFp = 1, and initial level of fibrinogen F 0g = 0.1.
Figure 4: Results of the basic simulation: a) clot size (red dashed) in time expressed in the number
of platelets, b) total thrombin concentration (blue solid), c) total fibrinogen concentration (cyan
solid), and d) total fibrin polymer concentration (green solid) expressed in non-dimensional units.
Note that the clot size and concentration values are drawn on the same scale. However, for the
clot size curve (red dashed) the scale denotes the total number of platelets in the clot, while for
thrombin, fibrinogen and fibrin polymer curves the scale denotes the total concentration of the
respective blood factor (expressed in non-dimensional units).
In Figure 4 the clot size and the total concentrations of thrombin, fibrinogen and fibrin polymer
in time are shown for the basic simulation. The value of a total concentration is obtained by
integration over the whole simulation domain. The clot size, measured in the number of platelets
(red dashed curve), shows the moments of the detachments of the weaker outer parts of the clot
due to the increased pressure from the flow on the clot. At the end clot stops growing in size. The
other three curves denote total concentrations in the simulation area of thrombin (blue), fibrinogen
(cyan) and fibrin polymer (green). The thrombin concentration at first grows due to the initial
concentration produced at the injury site and the presence of the tissue factor, and it continues to
grow until it fills the whole platelet aggregate. The concentration which diffuses outside of the
clot is taken away by the flow. Thus the total thrombin concentration remains limited by the clot
size, and it is suddenly reduced when some parts of the clot detach. On the other hand fibrinogen
is constantly present in the flow and it accumulates inside of the clot by inflow and diffusion. In
presence of thrombin fibrinogen is consumed in the process of the production of fibrin polymer.
Finally, the fibrin polymer concentration rises inside of the growing clot but is being limited by
its size as thrombin is present only inside of the clot. Sudden changes in the growth rate of fibrin
polymer are noticeable at the moments of the detachments of the outer parts of the clot.
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Figure 5: Variation of the initial fibrinogen level F 0g from 0.01 to 0.5: a) clot size in time, b) total
thrombin concentration in time, c) total fibrinogen concentration in time, d) total fibrin polymer
concentration in time.
Physiologically, there exist three types of fibrinogen deficiency [1]: dysfibrinogenemia, hy-
pofibrogenemia and afibrinogenemia. In the case of dysfibrinogenemia the level of fibrinogen in
blood is normal (1.5-3.5 g/L), however the fibrinogen does not function properly due to genetic
mutations. Depending on the type of mutation dysfibrinogenemia can be either asymptomatic, or
can cause bleeding or thrombosis. Hypofibrogenemia is a deficiency which manifests in lower than
normal level of fibrinogen in blood (0.1-1.5 g/L). As the level of fibrinogen is lower, the condition
will lead to more bleeding. Finally, afibrinogenemia denotes a complete lack of fibrinogen in blood
(<0.1 g/L), which causes serious bleeding.
10
A. Tosenberger et al. Influence of fibrinogen deficiency on clot formation in flow
Figure 6: Variation of the fibrin polymer production rate coefficient k03 from 0.6 to 30 min
−1: a)
clot size in time, b) total thrombin concentration in time, c) total fibrinogen concentration in time,
d) total fibrin polymer concentration in time.
Using the described model we first study the influence of the initial fibrinogen concentration
(F 0g ) on the clot formation. Figure 5 shows the clot size and the total concentration of blood factors
at different initial fibrinogen concentrations, ranging from 0.01 to 0.5. At the beginning (the first
15 seconds) the clot size increases with approximately the same rate in all simulations except the
one with F 0g = 0.01. However, the higher level of fibrinogen results in a faster fibrin polymer
production, thus allowing the clot to grow larger. Thrombin concentrations also remain similar
in the first 15 seconds, reflecting the sizes of the corresponding clots. Fibringen concentrations
rise due to the higher initial level and its accumulation in the clot. Finally, the fibrin polymer
concentration growth rate is at first increased due to the increased initial fibrinogen concentrations,
while later on it becomes limited by the clot size. For the initial level of fibrinogen of 0.01 the
11
A. Tosenberger et al. Influence of fibrinogen deficiency on clot formation in flow
production of fibrin polymer is too low to support the growing platelet aggregate. The platelet clot
breaks off, and leaves the injury site insufficiently protected. These results qualitatively correspond
to the cases of normal, low (hypofibrogenemia) and too low (afibrinogenemia) levels of fibrinogen
in blood.
Next, we vary the reaction rate constant of fibrin polymer production. Figure 6 shows the clot
size and total concentration of blood factors for values of k03 ranging from 0.6 to 30 min
−1. For
low rates of fibrin polymer production (here 0.6 to 3 min−1) the clot is unable to form as its critical
size is achieved before it is supported by the fibrin net, which results in the complete detachment
of the initial platelet aggregate and the removal of the thrombin concentration by the flow. As the
production rate increases (6, 15 and 30 min−1), the clot grows to a larger size since it is supported
by a faster fibrin net generation.
4. Discussion
The model presented in this work is a minimal model of clot development in flow, which can cap-
ture the platelet aggregate - coagulation pathway interaction. It can be used for further refinements
by the introduction of more complete models of blood cells and of the regulatory network. In
this work we use it to study the impacts of protein concentrations and reaction rates on the clot
development and its final size. Furthermore, the regulatory network is described in a form which is
simplified but takes into account the main characteristics of coagulation pathways in vivo: the ini-
tial production of thrombin at the injury site due to the presence of tissue factor, the self-accelerated
production of thrombin, the constant presence of fibrinogen in the blood flow and the production
of fibrin polymer in the presence of thrombin. Furthermore, the model takes into account the acti-
vation of platelets by surrounding aggregated platelets, and the interaction of platelets with fibrin
polymer, while other interactions of platelets with the coagulation cascade [14] are omitted. Thus
the model is phenomenological and able to produce qualitative rather than quantitative results. As
such it serves for studying qualitative aspects of blood coagulation, and we use it here to investigate
the influence which the initial fibrinogen level and the fibrin polymer production rate can have on
the clot formation in the flow. These results will be used in the upcoming development of a more
complete model of clot formation in flow, which will also include a more extensive model of blood
coagulation pathways.
The described model is a 2D model, and it takes into account the flow of blood plasma and
platelets. Red blood cells and the third dimension are deliberately omitted in order to reduce
the complexity of the model and the time necessary to simulate the process of clot growth and
arrest. However, the described hybrid model can be extended in order to simulate a 3D flow and/or
different types of blood cells. In [6, 7] the discrete part of the model (DPD) was coupled with
a model of erythrocytes and platelets, and used to simulate blood flow in 3D and to study the
distribution of the cells in flow. Due to the complexity of the process of clot formation in flow,
as well as the extensiveness of the numerical implementations and the computational costs, in the
future it will be equally important to continue developing both the 2D and the 3D model.
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